Whole genome sequence-based molecular characterization of blood isolates of carbapenem-resistant Enterobacter cloacae complex from ICU patients in Kolkata, India, during 2017–2022: emergence of phylogenetically heterogeneous Enterobacter hormaechei subsp. xiangfangensis

• DOI: 10.1128/spectrum.03529-23
• Publication Date: 2024-02-22T14:02:25Z
• Authors: Gourab Halder; Bhaskar Narayan C...; Subhranshu Mandal; Priyanka Denny; Deotima Sarkar; Mandira Chakraborty; Ujjwayini Ray Khan; Soma Sarkar; Bedobroto Biswas; Arindam Chakraborty; Sourav Maiti; Shanta Dutta
• Keywords: 0301 basic medicine; 03 medical and health sciences

ABSTRACT

Blood-borne infections caused by the carbapenem-resistant Enterobacter cloacae complex (CR-ECC) are major public threats with respect to the challenges encountered during treatment. This study describes the whole genome sequencing-based molecular characteristics of blood isolates ( n = 70) of CR-ECC from patients admitted to the intensive care unit of tertiary care hospitals in Kolkata, India, during 2017–2022 with respect to species identification, antimicrobial resistance (AMR) profiling, mechanism of drug resistance, and molecular subtypes. Vitek2 MALDI and species-specific PCR identified Enterobacter hormaechei subsp. xiangfangensis (47.14%) as the emerging CR-ECC subspecies in Kolkata. The predominating carbapenemase and extended-spectrum β-lactamase genes found were bla NDM-1 (51.42%) and bla CTX-M-15 (27%), respectively. Besides, bla NDM-4 , bla NDM-5 , bla NDM-7 , bla CMH-3 , bla SFO-1 , bla OXA-181 , bla OXA-232 , bla KPC-3 , and bla DHA-7 genes were also detected, which were not previously reported from India. A multitude of Class 1 integrons (including In180, In4874, In4887, and In4888, which were novel) and plasmid replicon types (IncFIB, IncFII, IncX3, IncHI1-HI2, IncC, and IncR) involved in AMR dissemination were identified. Reverse transcription-PCR and western blot revealed that carbapenem resistance in non-carbapenemase-producing CR-ECC isolates was contributed by elevated levels of ampC , overexpression of acrAB, and loss of ompF . A total of 30 distinct sequence types (STs) were ascertained by multi-locus sequence typing; of which, ST2011, ST2018, ST2055, ST2721, and ST2722 were novel STs. Pulsed-field gel electrophoresis analysis showed heterogeneity (69 pulsotypes with a similarity coefficient of 48.40%) among the circulating isolates, suggesting multiple reservoirs of infections in humans. Phylogenetically and genetically diverse CR-ECC with multiple AMR mechanisms mandates close monitoring of nosocomial infections caused by these isolates to forestall the transmission and dissemination of AMR.

IMPORTANCE

The emergence and extensive dissemination of the carbapenem-resistant Enterobacter cloacae complex (CR-ECC) have positioned it as a critical nosocomial global pathogen. The dearth of a comprehensive molecular study pertaining to CR-ECC necessitated this study, which is the first of its kind from India. Characterization of blood isolates of CR-ECC over the last 6 years revealed Enterobacter hormaechei subsp. xiangfangensis as the most prevalent subsp., exhibiting resistance to almost all antibiotics currently in use and harboring diverse transmissible carbapenemase genes. Besides the predominating bla NDM-1 and bla CTX-M-15 , we document diverse carbapenemase and AmpC genes, such as bla NDM-4 , bla NDM-7 , bla OXA-181 , bla OXA-232 , bla KPC-3 , bla CMH-3 , bla SFO-1 , and bla DHA-7 , in CR-ECC, which were not previously reported from India. Furthermore, novel integrons and sequence types were identified. Our findings emphasize the need for strengthened vigilance for molecular epidemiological surveillance of CR-ECC due to the presence of epidemic clones with a phylogenetically diverse and wide array of antimicrobial resistance genes in vulnerable populations.